Tricol Biomedical, Inc.

Tricol Biomedical is a leader in advanced acute wound care with products that provide rapid Hemorrhage Control (HemCon) of bleeding, protection of wounds, and promotion of normal healing. Tricol Biomedical is headquartered in Portland, Oregon with a European operation in the Czech Republic (HemCon Medical Technologies CZ s.r.o.). Through research and innovation, the company has delivered a wide range of proprietary and patent-protected OneStop, HemCon, and m.doc branded products for hemostasis to address the varying needs of patients and their healthcare professionals, military medics, paramedics, first responders, and consumers. We work to develop, manufacture, and market innovative hemostatic technologies that are safe, effective, and time-saving across many Pre-Hospital and Hospital specialties.